Vaxxas Appoints David Hoey as Company’s First CEO

You may also like

05 February 2018

OneVentures’ Investee Smart Sparrow Secures Strategic Investment from Global Education Leader

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

13 December 2016

OneVentures awarded Biomedical Translation $170M Funding

Announcement, Media Release

16 September 2018

VC-backed women’s health company Madorra to begin clinical trials in Australia

03 August 2020

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

31 October 2013

Hatchtech completes $12.5M capital raise, secures funds for phase III trial and NDA submissions, and announces board changes

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor